2020
DOI: 10.1038/s41375-020-0818-9
|View full text |Cite
|
Sign up to set email alerts
|

Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
92
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 66 publications
(93 citation statements)
references
References 51 publications
1
92
0
Order By: Relevance
“…Activation of neutrophil growth factor receptor signaling pathway induces proliferation and early stages of HSC differentiation. Activation of CD117 receptor by neutrophil growth factor potentiates a number of cytokine-dependent signaling pathways, thereby promoting proliferation and differentiation of HSC [3,12]. The CD117 molecule is involved in the maintenance of HSC population in the blood and bone marrow.…”
Section: Resultsmentioning
confidence: 99%
“…Activation of neutrophil growth factor receptor signaling pathway induces proliferation and early stages of HSC differentiation. Activation of CD117 receptor by neutrophil growth factor potentiates a number of cytokine-dependent signaling pathways, thereby promoting proliferation and differentiation of HSC [3,12]. The CD117 molecule is involved in the maintenance of HSC population in the blood and bone marrow.…”
Section: Resultsmentioning
confidence: 99%
“…In addition to hematopoietic stem cells and mast cells, interstitial cells of Cajal (ICCs) and melanocytes, epithelial cells, and certain cells in the reproductive organs are highly positive for CD117 [66−68]. In a recent publication, we used immunohistochemistry to compare CD117 expression patterns in several vital organs of humans and mice [69]. In summary, we found that low-level CD117 expression is more common than generally acknowledged and is, for example, present in tubular epithelial cells of the kidney or ovarian follicular cells.…”
Section: Expression Patterns In Mice and Humansmentioning
confidence: 99%
“…CD123 CAR-T cells are also in clinical development. CD117 CAR-T cells were recently reported to efficiently eliminate AML blasts as well as CD117 + healthy HSCs in the AML model [81]. CD117, a receptor tyrosine kinase to which stem cell factor binds, is expressed on hematopoietic precursors; however, it may remain overexpressed following malignant transformation in HSCs [82,83].…”
Section: Immunotherapy For Amlmentioning
confidence: 99%